Breaking News
Japan Posts Record Population Drop, Shrinking For 14th Year, As Demographic Crisis Deepens
Defund The Cartels: A Smarter Plan For The Border
Dollar Crashes On Powell Removal Speculation, Gold Soars To All Time High And Bitcoin...
How Might Washington's Relations With Ukraine & Russia Change If It Abandons Its Peace Efforts?
Top Tech News
'Cyborg 1.0': World's First Robocop Debuts With Facial Recognition And 360° Camera Visio
The Immense Complexity of a Brain is Mapped in 3D for the First Time:
SpaceX, Palantir and Anduril Partnership Competing for the US Golden Dome Missile Defense Contracts
US government announces it has achieved ability to 'manipulate space and time' with new tech
Scientists reach pivotal breakthrough in quest for limitless energy:
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
BREAKTHROUGH Testing Soon for Starship's Point-to-Point Flights: The Future of Transportation
Oligodendrocyte progenitor cells repair damaged spine in humans in clinical trial...
AST's technology comes from one of the leading companies in regenerative medicine, BioTime, Inc., (NYSE: BTX) which spun off Asterias Biotherapeutics a few years ago and is also its largest shareholder. It is also worth pointing out that BioTime's CEO, Dr. Michael West, is one of the world's leading experts in regenerative and stem cell research
Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine. The company's proprietary cell therapy programs are based on its immunotherapy and pluripotent stem cell platform technologies. Asterias is presently focused on advancing three clinical-stage programs which have the potential to address areas of very high unmet medical need in the fields of oncology and neurology.
Dr Michael West will use regenerative stem cell medicine to solve the primary diseases of aging.